In Brief: NSAID/breast cancer study
This article was originally published in The Tan Sheet
Executive Summary
NSAID/breast cancer study: Ohio State University study concludes that NSAIDs "may have chemopreventive potential against the development of breast cancer." Researchers, led by Ohio's Randall Harris, screened 1,534 women without breast cancer and 511 women with newly diagnosed breast cancer for NSAID use according to type, frequency of intake and duration of use. The researchers determined that risk declined with increasing NSAID exposure; the greatest risk reduction (40%) coincided with daily intake for five or more years. The study, which was funded by the National Cancer Institute, is published in the March issue of Epidemiology...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning